Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl V Asche

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Pharmacoeconomics|December 21, 2013
Review of models used in economic analyses of new oral treatments for type 2 diabetes mellitusCarl V Asche, Stephen E Hippler, Dean T Eurich
Journal of Health Economics and Outcomes Research|September 28, 2022
Economic Outcomes and Incidence of Postsurgical Hypotension With Liposomal Bupivacaine vs Epidural Analgesia in Abdominal SurgeriesMargaret Holtz, Nick Liao, Jennifer H Lin, et al.
Plos One|February 12, 2019
Long-term effectiveness of a gambling intervention program among children in central IllinoisJinma Ren, Kirk Moberg, Heidi Scuffham, et al.
Current Medical Research and Opinion|June 3, 2010
The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorderCarl V Asche, Vijay N Joish, Fabian Camacho, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Efficacy, patient-reported outcomes (PROs), and tolerability of the changing therapeutic landscape in patients with metastatic prostate cancer (MPC): a systematic literature reviewBrian S Seal, Carl V Asche, Katarzyna Puto, et al.
Clinical and Experimental Rheumatology|November 8, 2019
Hereditary, socio-behavioural, and immuno-hormonal predictors of incident rheumatoid arthritis and therapy response influences on survival versus matched control subjects using a generalised structural equation modelJinma Ren, Alfonse T Masi, Jean C Aldag, et al.
Spine|June 9, 2016
Cost-Effectiveness of Primary Care Management With or Without Early Physical Therapy for Acute Low Back Pain: Economic Evaluation of a Randomized Clinical TrialJulie M Fritz, Minchul Kim, John S Magel, et al.
Journal of Pain & Palliative Care Pharmacotherapy|August 26, 2006
Economic evaluations in pain management: principles and methodsCarl V Asche, Brian Seal, Kenneth C Jackson, et al.
Pharmacoeconomics|June 9, 2020
Future of Data Analytics in the Era of the General Data Protection Regulation in EuropeKatarzyna Kolasa, W Ken Redekop, Alexander Berler, et al.
Journal of Managed Care Pharmacy : JMCP|November 12, 2010
All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United StatesCarl V Asche, Mendel E Singer, Mehul Jhaveri, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Pharmacoeconomics|December 21, 2013
Review of models used in economic analyses of new oral treatments for type 2 diabetes mellitusCarl V Asche, Stephen E Hippler, Dean T Eurich
Journal of Health Economics and Outcomes Research|September 28, 2022
Economic Outcomes and Incidence of Postsurgical Hypotension With Liposomal Bupivacaine vs Epidural Analgesia in Abdominal SurgeriesMargaret Holtz, Nick Liao, Jennifer H Lin, et al.
Plos One|February 12, 2019
Long-term effectiveness of a gambling intervention program among children in central IllinoisJinma Ren, Kirk Moberg, Heidi Scuffham, et al.
Current Medical Research and Opinion|June 3, 2010
The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorderCarl V Asche, Vijay N Joish, Fabian Camacho, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Efficacy, patient-reported outcomes (PROs), and tolerability of the changing therapeutic landscape in patients with metastatic prostate cancer (MPC): a systematic literature reviewBrian S Seal, Carl V Asche, Katarzyna Puto, et al.
Clinical and Experimental Rheumatology|November 8, 2019
Hereditary, socio-behavioural, and immuno-hormonal predictors of incident rheumatoid arthritis and therapy response influences on survival versus matched control subjects using a generalised structural equation modelJinma Ren, Alfonse T Masi, Jean C Aldag, et al.
Spine|June 9, 2016
Cost-Effectiveness of Primary Care Management With or Without Early Physical Therapy for Acute Low Back Pain: Economic Evaluation of a Randomized Clinical TrialJulie M Fritz, Minchul Kim, John S Magel, et al.
Journal of Pain & Palliative Care Pharmacotherapy|August 26, 2006
Economic evaluations in pain management: principles and methodsCarl V Asche, Brian Seal, Kenneth C Jackson, et al.
Pharmacoeconomics|June 9, 2020
Future of Data Analytics in the Era of the General Data Protection Regulation in EuropeKatarzyna Kolasa, W Ken Redekop, Alexander Berler, et al.
Journal of Managed Care Pharmacy : JMCP|November 12, 2010
All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United StatesCarl V Asche, Mendel E Singer, Mehul Jhaveri, et al.
Pageof 8